Literature DB >> 32290348

COVID-19: A Brief Overview of the Discovery Clinical Trial.

Jean Jacques Vanden Eynde1.   

Abstract

The outbreak of COVID-19 is leading to a tremendous search for curative treatments. The urgency of the situation favors a repurposing of active drugs but not only antivirals. This short communication focuses on four treatments recommended by WHO and included in the first clinical trial of the European Discovery project.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; chloroquine; hydroxychloroquine; lopinavir/ritonavir; remdesivir; repurposing

Year:  2020        PMID： 32290348     DOI： 10.3390/ph13040065

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN： 1424-8247


  12 in total

1.  A bibliometric analysis using VOSviewer of publications on COVID-19.

Authors:  Yuetian Yu; Yujie Li; Zhongheng Zhang; Zhichun Gu; Han Zhong; Qiongfang Zha; Luyu Yang; Cheng Zhu; Erzhen Chen
Journal:  Ann Transl Med       Date:  2020-07

2.  COVID-19: An Update About the Discovery Clinical Trial.

Authors:  Jean Jacques Vanden Eynde
Journal:  Pharmaceuticals (Basel)       Date:  2020-05-14

Review 3.  Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update.

Authors:  Shikha Thakur; Bibekananda Sarkar; Arshad J Ansari; Akanksha Khandelwal; Anil Arya; Ramarao Poduri; Gaurav Joshi
Journal:  Food Chem Toxicol       Date:  2020-11-27       Impact factor: 6.023

Review 4.  COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis.

Authors:  Bin Wang; Junkai Lai; Xiaoyan Yan; Feifei Jin; Bin Yi; Caixia An; Yuanxiao Li; Chen Yao
Journal:  Drug Des Devel Ther       Date:  2020-11-19       Impact factor: 4.162

Review 5.  Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19.

Authors:  Beatriz Fernandez-Fernandez; Luis D'Marco; Jose Luis Górriz; Conxita Jacobs-Cachá; Mehmet Kanbay; Sergio Luis-Lima; Esteban Porrini; Pantelis Sarafidis; María José Soler; Alberto Ortiz
Journal:  J Clin Med       Date:  2020-06-28       Impact factor: 4.241

Review 6.  Antiviral peptides from aquatic organisms: Functionality and potential inhibitory effect on SARS-CoV-2.

Authors:  Tofael Ahmed Sumon; Md Ashraf Hussain; Mahmudul Hasan; Aminur Rashid; Muyassar Hamid Abualreesh; Won Je Jang; S M Sharifuzzaman; Christopher Lyon Brown; Eun-Woo Lee; Md Tawheed Hasan
Journal:  Aquaculture       Date:  2021-04-15       Impact factor: 5.135

7.  Binding ability of arginine, citrulline, N-acetyl citrulline and thiocitrulline with SARS COV-2 main protease using molecular docking studies.

Authors:  Ramesh Thimmasandra Narayan
Journal:  Netw Model Anal Health Inform Bioinform       Date:  2021-04-06

8.  SARS-CoV-2 Infection with Different Radiological Insights.

Authors:  Barbara Brogna; Claudia Brogna; Alberigo Martino; Stefana Minichiello; Domenico M Romeo; Paolo Romano; Elio Bignardi; Emerico Maria Mazza; Lanfranco Musto
Journal:  Diagnostics (Basel)       Date:  2020-05-07

9.  Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).

Authors:  Shuofeng Yuan; Chris Chun-Yiu Chan; Kenn Ka-Heng Chik; Jessica Oi-Ling Tsang; Ronghui Liang; Jianli Cao; Kaiming Tang; Jian-Piao Cai; Zi-Wei Ye; Feifei Yin; Kelvin Kai-Wang To; Hin Chu; Dong-Yan Jin; Ivan Fan-Ngai Hung; Kwok-Yung Yuen; Jasper Fuk-Woo Chan
Journal:  Viruses       Date:  2020-06-10       Impact factor: 5.048

10.  COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now-New Hopes?

Authors:  Jean Jacques Vanden Eynde
Journal:  Pharmaceuticals (Basel)       Date:  2021-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.